Full text is available at the source.
Abstract
GLP-1 receptor agonists are increasingly prescribed in the UK for managing obesity and diabetes.
- There is limited dental literature addressing the effects of GLP-1 receptor agonists on the facial profile and oral cavity.
- Dentists and dental care professionals are likely to encounter patients using these medications without clear guidance.
- Awareness of the potential oral and facial effects of GLP-1 receptor agonists is essential for dental practitioners.
- Improved knowledge among dental professionals may support better patient management.
- Further research focused on dental implications of these medications is needed.
Simplified